Patent ID: 7358261

Claim:
A compound of Formula (I): wherein: A is Y is one to three substituents independently selected from the group consisting of halogen and C 1-8 alkyl; L is: in which R 5 is selected from the group consisting of hydrogen, C 1-8 alkyl, C 2-8 alkenyl and aryl(C 1-8 )alkyl wherein aryl is optionally substituted with one or more substituents independently selected from the group consisting of C 1-8 alkyl, C 1-8 alkoxy, [(C 1-8 )alkyl] 2 N—, halogen, and cyano; M is selected from the group consisting of C 1-8 alkylene and C 2-8 alkenylene; Z is (N—R 6 )pyrrolylene optionally substituted with one or two C 1-4 alkyl substituents; R 6 is independently selected from the group consisting of C 1-8 alkyl, C 2-8 alkenyl, C 3-8 cycloalkyl(C 1-8 )alkyl and aryl(C 1-8 )alkyl wherein aryl is optionally substituted with one or more substituents independently selected from the group consisting of C 1-8 alkyl, C 1-8 alkoxy, [(C 1-8 s)alkyl] 2 N—, halogen, and cyano; D is —C(O)—; R 1 is (R 7 )phenyl; R 7 is one or two substituents independently selected from the group consisting of hydrogen, C 1-8 alkyl, C 2-8 alkenyl, C 2-8 alkynyl, C 3-8 cycloalkyl, aryl(C 1-8 )alkyl, C 1-8 alkoxy, aryloxy, aryl(C 1-8 alkoxy, C 1-8 alkylthio, trifluoro(C 1-8 )alkyl, trifluoro(C 1-8 )alkoxy, heterocyclyl(C 1-8 )alkyl, methylenedioxy, amino, —NH(C 1-8 )alkyl, —N[(C 1-8 )alkyl] 2 , —NH(aryl), —N(aryl) 2 , —NH(C 1-8 )alkylaryl, —N[(C 1-8 )alkylaryl] 2 , —CO 2 (C 1-8 )alkyl, —CO 2 (aryl), —C(O)NH 2 , —C(O)NH(C 1-8 )alkyl, —C(O)N[(C 1-8 )alkyl] 2 , —NHC(O)(C 1-8 )alkyl, (C 1-8 alkyl) 2 —N—(C 1-8 )alkyl, S(O)(C 1-8 )alkyl, —SO 2 (C 1-8 )alkyl, —SO 2 NH 2 , —SO 2 NH(C 1-8 )alkyl, —SO 2 N[(C 1-8 )alkyl] 2 , —C(O)(C 1-8 )alkyl, —C(O)aryl, —C(O)(C 1-8 )alkylaryl, halogen, hydroxy, cyano, nitro, phenyl, a 5-membered monocyclic aromatic ring containing one O, S, or N atom and up to three additional N atoms, a 6-membered monocyclic aromatic ring containing at least one N atom and up to two additional N atoms, and a partially saturated or unsaturated 5- or 6-membered monocyclic ring having one O, S or N atom which optionally contains up to one additional O, S or N atom; and pharmaceutically acceptable enantiomers, diastereomers and salts thereof.